Few studies have examined long-term outcomes following oral immunotherapy (OIT); none have examined long-term risks and benefits associated with distinct clinical outcomes (desensitization, remission).
No takes yet. Share an insight, caveat, or question.
Loke et al. (2024) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: